| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9393 |
| Human Intestinal Absorption | HIA+ | 0.8971 |
| Caco-2 Permeability | Caco2+ | 0.6469 |
| P-glycoprotein Substrate | Non-substrate | 0.7142 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9405 |
| Non-inhibitor | 0.9505 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9189 |
| Distribution |
| Subcellular localization | Mitochondria | 0.9227 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7551 |
| CYP450 2D6 Substrate | Non-substrate | 0.9351 |
| CYP450 3A4 Substrate | Non-substrate | 0.7630 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8902 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9636 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9574 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9616 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9852 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9712 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9761 |
| Non-inhibitor | 0.9831 |
| AMES Toxicity | Non AMES toxic | 0.9572 |
| Carcinogens | Non-carcinogens | 0.7638 |
| Fish Toxicity | High FHMT | 0.8873 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8115 |
| Honey Bee Toxicity | High HBT | 0.6182 |
| Biodegradation | Ready biodegradable | 0.8192 |
| Acute Oral Toxicity | IV | 0.5671 |
| Carcinogenicity (Three-class) | Non-required | 0.7437 |